TFPI, as the precursor mRNA of hsa_circ_0057335, has been proved to be closely related to the increased expression of CD33 in CHOL [30] and the decreased expression of TFPI‐2 may inhibit cell migration and tumor invasion, playing an essential role in the carcinogenesis and progression of CHOL. The gene discussed is CD33; the disease is neoplasm.